AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

  Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience AliveCor, maker of an innovative, FDA-cleared, personal electrocardiogram (ECG) technology, has partnered with the Jefferson Narcotic Addiction Rehabilitation…

Read More